3,4-methylenedioxymethamphetamine (mdma): A review
- 1 November 2001
- journal article
- review article
- Published by Springer Nature in Current Psychiatry Reports
- Vol. 3 (6) , 477-483
- https://doi.org/10.1007/s11920-001-0041-y
Abstract
This article reviews the history, pharmacology, and adverse events associated with the use of 3,4-methylenendioxymethamphetamine (MDMA), commonly known as Ecstasy. Past research describing the neurotoxic effects of MDMA in animals, current research on the neurotoxic effects of MDMA in humans, and the attendant changes in psychologic functioning will be highlighted in this review. Finally, the limitations of human research on the effects of MDMA and suggestions for future MDMA research will be discussed.Keywords
This publication has 82 references indexed in Scilit:
- Long-term effects of ‘ecstasy’ abuse on the human brain studied by FDG PETNuclear Medicine Communications, 2001
- Patterns of recreational drug use at dance events in Edinburgh, ScotlandAddiction, 2001
- Psychobiological problems in heavy 'ecstasy' (MDMA) polydrug usersDrug and Alcohol Dependence, 2000
- Mood and cognitive effects of ± 3,4-methylenedioxymethamphetamine (MDMA, ‘ecstasy’): week-end ‘high’ followed by mid-week lowAddiction, 1997
- Chronic ecstasy (3,4-methylenedioxymetamphetamine) abuse: a recurrent and unpredictable cause of severe acute hepatitisJournal of Hepatology, 1996
- Hepatotoxicity and Accelerated Fibrosis Following 3,4-Methylenedioxymetamphetamine (“Ecstasy”) UsageJournal of Clinical Gastroenterology, 1995
- Psychiatric illness associated with "ecstasy"The Lancet, 1991
- ‘Ecstasy’ Psychosis and FlashbacksThe British Journal of Psychiatry, 1991
- Du Pont Backs Phaseout of CFCsScience, 1988
- Incidence of Recreational Use of 3,4-Methylenedimethoxymethamphetamine (MDMA, Ecstasy) on an Undergraduate CampusNew England Journal of Medicine, 1987